Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial

Interact Cardiovasc Thorac Surg. 2010 Dec;11(6):758-62. doi: 10.1510/icvts.2010.243600. Epub 2010 Sep 16.

Abstract

The purpose of this study was to test, whether the late phase of remote ischaemic preconditioning (L-RIPC) improves myocardial protection in coronary artery bypass grafting (CABG) with cold-crystalloid cardioplegia and whether preoperative tramadol modifies myocardial ischaemia-reperfusion injury using the same group of patients in a single-blinded randomized controlled study. One hundred and one adult patients were randomly assigned to either the L-RIPC, control or tramadol group. L-RIPC consisted of three five-minute cycles of upper limb ischaemia and three five-minute pauses using blood pressure cuff inflation 18 hours prior to the operation. Patients in the tramadol group received 200 mg tramadol retard at 19:00 hours, the day before the operation and at 06:00 hours. Serum troponin I levels were measured at eight, 16 and 24 hours after surgery. Myocardial samples for inducible and endothelial nitric oxide synthases (iNOS, eNOS) estimation were drawn twice: before and after cannulation for cardiopulmonary bypass from the auricle of the right atrium. We found that L-RIPC can reduce injury beyond the myocardial protection provided by cold-crystalloid cardioplegia, and tramadol worsened myocardial injury after CABG. Expressions of iNOS were increased in the control (significantly) and L-RIPC groups and dampened in the tramadol group.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Analgesics, Opioid / adverse effects*
  • Biomarkers / blood
  • Coronary Artery Bypass / adverse effects*
  • Czech Republic
  • Female
  • Heart Arrest, Induced
  • Heart Diseases / chemically induced
  • Heart Diseases / etiology*
  • Heart Diseases / metabolism
  • Heart Diseases / prevention & control*
  • Humans
  • Hypothermia, Induced
  • Ischemic Preconditioning*
  • Male
  • Middle Aged
  • Myocardium / enzymology
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide Synthase Type III / metabolism
  • Potassium Compounds / administration & dosage
  • Single-Blind Method
  • Time Factors
  • Tramadol / adverse effects*
  • Treatment Outcome
  • Troponin I / blood

Substances

  • Analgesics, Opioid
  • Biomarkers
  • Potassium Compounds
  • Troponin I
  • potassium cardioplegic solution
  • Tramadol
  • NOS2 protein, human
  • NOS3 protein, human
  • Nitric Oxide Synthase Type II
  • Nitric Oxide Synthase Type III